Insulet
(Nasdaq: PODD)
announced today that Wayde McMillan decided to leave his role as EVP, CFO and treasurer.
McMillan’s departure goes into effect on Oct. 20, 2023. He intends to join 3M as CFO of its Health Care business, which the company expects to spin off late this year or early next year.
President and CEO Jim Hollingshead called McMillan “a trusted partner and an excellent leader” of the company’s global finance team. He said McMillan helped to advance Insulet’s mission of improving the lives of people with diabetes.
“Wayde has helped make our company stronger and more resilient, ensuring we have the capabilities and financial strength to capitalize on the tremendous long-term growth opportunities Insulet is pursuing,” Hollingshead said in a news release. “On behalf of the board and our entire team, I thank Wayde for his many contributions and wish him well in his future endeavors.”
McMillan called it an honor to work at Insulet alongside a talented team and deliver on the company’s mission. He cited pride in the company’s accomplishments in his four-and-a-half years there.
Get the full story at our sister site, Drug Delivery Business News.